Fifth U.S. Circuit Court of Appeals Temporarily Halts Biden Vaccine Mandate
On Nov. 8, 2021, the U.S. Court of Appeals for the Fifth Circuit, covering parts of Texas, Mississippi and Louisiana, put a temporary stop to the Biden administration’s vaccine mandate announcing…
Federal Employees Fight COVID Vaccine Mandates in Court
With a looming deadline of Nov. 22, 2021, thousands of federal employees and contractors continue to push back against the Biden administration’s sweeping COVID vaccine mandates. According to The Washington Post, tens of thousands of federal employees remain unvaccinated pending word on whether religious or medical exemptions will be approved. Federal employees who fail to […]
Tennessee Man Dies Three Days After Getting Second Pfizer COVID Shot
A 36-year-old man in Madison County, Tennessee died unexpectedly on Sept. 25, 2021, three days after receiving the second dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19. Timothy Adam Hornsby was vaccinated on Sept. 22 and started feeling ill the next morning. His health took a turn for the worse two days […]
Tracking the Mutations of the SARS-CoV-2 Virus
As is the nature of viruses, the SARS-CoV-2 virus that causes COVID-19 disease symptoms continues to mutate. Some scientists estimate it evolves at a rate of two new mutations every month, although most changes are minor and considered clinically unimportant.1 2 Depending on the type of genetic changes that occur, mutations can affect disease symptoms, […]
CDC Recommends Four COVID-19 Shots for Immunocompromised People
On Oct. 25, 2021, the U.S. Centers for Disease Control and Prevention (CDC) updated its COVID-19 vaccine guidance for moderately to severely immunocompromised people over the age of 18 years to include a total of four doses of a COVID-19 biologic.1 Moderate to Severely Immune Compromised People Can Get A Fourth COVID Shot Six Months […]
FDA, CDC Green Light Pfizer’s Experimental COVID Biologic for Children 5 to 11 Years Old
One Oct 29, 2021, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the experimental messenger RNA (mRNA) Pfizer/BioNTech COVID-19 biologic BNT162b2 for children five to 11 years old. The FDA’s decision, which is based on a clinical trial earlier this year involving 2,268 kindergartners and elementary school-aged kids and an […]